Literature DB >> 12354852

Identification of Candida glabrata by a 30-second trehalase test.

A-M Freydière1, F Parant, F Noel-Baron, M Crepy, A Treny, H Raberin, A Davidson, F C Odds.   

Abstract

Rapid (30-s) trehalase tests done with material from colonies of 482 yeasts suspended in a drop of trehalose solution on a commercially supplied glucose test strip were positive for 225 (99.1%) of 227 Candida glabrata isolates grown on either of two differential media, Candida ID medium or CandiSelect medium. The test was positive for only 3 (1.2%) and 12 (4.7%) of 255 isolates of other medically important yeast species grown on the same two media, respectively. A rapid maltase test done with a subset of 255 yeast isolates was negative for all but 1 of 64 trehalase-positive C. glabrata isolates, raising the specificity of the rapid testing for C. glabrata to 98.4 to 100%, depending on the isolation medium used. Rapid trehalase and maltase tests done independently in two laboratories with 217 yeast isolates showed sensitivities of 96.0 to 98.0% and specificities of 98.2 to 99.4% for identification of C. glabrata from colonies grown on Candida ID medium. The specificity was much lower because of frequent false-positive trehalose test results when the source of colonies was Sabouraud agar formulated with 4% glucose. We conclude that direct recognition of C. albicans as blue colonies on Candida ID isolation medium coupled with the performance of the 30-s trehalase and maltase tests for C. glabrata among the white colonies on this medium will allow the rapid presumptive identification of the two yeast species most commonly encountered in clinical samples.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12354852      PMCID: PMC130844          DOI: 10.1128/JCM.40.10.3602-3605.2002

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  22 in total

Review 1.  Yeast identification in the clinical microbiology laboratory: phenotypical methods.

Authors:  A M Freydiere; R Guinet; P Boiron
Journal:  Med Mycol       Date:  2001-02       Impact factor: 4.076

2.  Evaluation of a reformulated CHROMagar Candida.

Authors:  M A Jabra-Rizk; T M Brenner; M Romagnoli; A A Baqui; W G Merz; W A Falkler; T F Meiller
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

3.  Bloodstream infections due to Candida species: SENTRY antimicrobial surveillance program in North America and Latin America, 1997-1998.

Authors:  M A Pfaller; R N Jones; G V Doern; H S Sader; S A Messer; A Houston; S Coffman; R J Hollis
Journal:  Antimicrob Agents Chemother       Date:  2000-03       Impact factor: 5.191

4.  Umbelliferyl-labeled galactosaminide as an aid in identification of Candida albicans.

Authors:  J L Perry; G R Miller
Journal:  J Clin Microbiol       Date:  1987-12       Impact factor: 5.948

5.  Performance of candida ID, a new chromogenic medium for presumptive identification of Candida species, in comparison to CHROMagar Candida.

Authors:  B Willinger; C Hillowoth; B Selitsch; M Manafi
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

6.  Rapid identification of yeasts in positive blood cultures by a multiplex PCR method.

Authors:  H C Chang; S N Leaw; A H Huang; T L Wu; T C Chang
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

7.  Comparison of four methodologies for rapid and cost-effective identification of Candida glabrata.

Authors:  J P Fenn; E Billetdeaux; H Segal; L Skodack-Jones; P E Padilla; M Bale; K Carroll
Journal:  J Clin Microbiol       Date:  1999-10       Impact factor: 5.948

8.  Trends in frequency and susceptibilities of Candida glabrata bloodstream isolates at a university hospital.

Authors:  J W Baddley; A M Smith; S A Moser; P G Pappas
Journal:  Diagn Microbiol Infect Dis       Date:  2001-03       Impact factor: 2.803

9.  Evaluation of Candida ID, a new chromogenic medium for fungal isolation and preliminary identification of some yeast species.

Authors:  H Fricker-Hidalgo; S Orenga; B Lebeau; H Pelloux; M P Brenier-Pinchart; P Ambroise-Thomas; R Grillot
Journal:  J Clin Microbiol       Date:  2001-04       Impact factor: 5.948

10.  Candida infections in surgical patients.

Authors:  P K Marsh; F P Tally; J Kellum; A Callow; S L Gorbach
Journal:  Ann Surg       Date:  1983-07       Impact factor: 12.969

View more
  10 in total

1.  Comparison of a new commercial test, GLABRATA RTT, with a dipstick test for rapid identification of Candida glabrata.

Authors:  Birgit Willinger; Susanne Wein; Alexander M Hirschl; Manfred L Rotter; Mammad Manafi
Journal:  J Clin Microbiol       Date:  2005-01       Impact factor: 5.948

2.  Multicenter evaluation of a Candida albicans peptide nucleic acid fluorescent in situ hybridization probe for characterization of yeast isolates from blood cultures.

Authors:  D A Wilson; M J Joyce; L S Hall; L B Reller; G D Roberts; G S Hall; B D Alexander; G W Procop
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

Review 3.  Biology of the pathogenic yeast Candida glabrata.

Authors:  A Bialková; J Subík
Journal:  Folia Microbiol (Praha)       Date:  2006       Impact factor: 2.099

4.  Azole resistance in Candida glabrata: coordinate upregulation of multidrug transporters and evidence for a Pdr1-like transcription factor.

Authors:  John-Paul Vermitsky; Thomas D Edlind
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

5.  Routine use of a commercial test, GLABRATA RTT, for rapid identification of Candida glabrata in six laboratories.

Authors:  A M Freydiere; J D Perry; O Faure; B Willinger; A M Tortorano; A Nicholson; J Peman; P E Verweij
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

6.  Comparison of VITEK 2 with ITS2-fragment length polymorphism analysis for identification of yeast species.

Authors:  Caroline Massonet; Johan Van Eldere; Mario Vaneechoutte; Thierry De Baere; Jan Verhaegen; Katrien Lagrou
Journal:  J Clin Microbiol       Date:  2004-05       Impact factor: 5.948

7.  Routine use of a one minute trehalase and maltase test for the identification of Candida glabrata in four laboratories.

Authors:  M A Piens; J D Perry; H Raberin; F Parant; A M Freydière
Journal:  J Clin Pathol       Date:  2003-09       Impact factor: 3.411

8.  Rapid identification of Candida glabrata with a new commercial test, GLABRATA RTT.

Authors:  A-M Freydiere; R Robert; C Ploton; A Marot-Leblond; F Monerau; F Vandenesch
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948

9.  Diversity and antifungal susceptibility of Norwegian Candida glabrata clinical isolates.

Authors:  Kari-Mette Andersen; Anne Karin Kristoffersen; André Ingebretsen; Katharina Johnsen Vikholt; Ulf Thore Örtengren; Ingar Olsen; Morten Enersen; Peter Gaustad
Journal:  J Oral Microbiol       Date:  2016-02-08       Impact factor: 5.474

10.  Biosynthesis of Silver Nanoparticles from Oropharyngeal Candida glabrata Isolates and Their Antimicrobial Activity against Clinical Strains of Bacteria and Fungi.

Authors:  Mohammad Jalal; Mohammad Azam Ansari; Mohammad A Alzohairy; Syed Ghazanfar Ali; Haris M Khan; Ahmad Almatroudi; Kashif Raees
Journal:  Nanomaterials (Basel)       Date:  2018-08-01       Impact factor: 5.076

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.